BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18223289)

  • 1. Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
    Kroschinsky FP; Schäkel U; Fischer R; Mohr B; Oelschlaegel U; Repp R; Schaich M; Soucek S; Baretton G; Ehninger G; Thiede C;
    Haematologica; 2008 Feb; 93(2):283-6. PubMed ID: 18223289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
    Park BG; Chi HS; Jang S; Park CJ; Kim DY; Lee JH; Lee JH; Lee KH
    Ann Hematol; 2013 Apr; 92(4):451-7. PubMed ID: 23238897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
    Mori Y; Yoshimoto G; Kumano T; Miyamoto T; Iino T; Takenaka K; Iwasaki H; Harada N; Kinukawa N; Nagafuji K; Teshima T; Shimoda K; Akashi K; Harada M
    Eur J Haematol; 2007 Jul; 79(1):17-24. PubMed ID: 17598835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.
    Haferlach T; Bacher U; Alpermann T; Haferlach C; Kern W; Schnittger S
    Leuk Res; 2012 Jan; 36(1):51-8. PubMed ID: 21621842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia.
    Obermann EC; Arber C; Jotterand M; Tichelli A; Hirschmann P; Tzankov A
    Ann Hematol; 2010 Jul; 89(7):663-9. PubMed ID: 20066533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of FLT3 mutations does not impair stem cell mobilization and feasibility of autologous peripheral blood stem cell transplantation in acute myeloid leukemia.
    Ferrara F; Palmieri S; Pollio F; Lo Pardo C; Graziano D; Celentano M; D'Amico MR; Vicari L; Izzo B; Pane F
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):981-6. PubMed ID: 16920565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?
    Bennett JM; Pryor J; Laughlin TS; Rothberg PG; Burack WR
    Am J Clin Pathol; 2010 Oct; 134(4):648-52. PubMed ID: 20855646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cup-like Blasts in 2 Pediatric Patients With NPM-1-Positive Acute Myeloid Leukemia.
    Tüfekçi Ö; Erdem M; Ören H; Yilmaz Ş
    J Pediatr Hematol Oncol; 2018 May; 40(4):e237-e238. PubMed ID: 29432313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression.
    Syampurnawati M; Tatsumi E; Furuta K; Takenokuchi M; Nakamachi Y; Kawano S; Kumagai S; Saigo K; Matsui T; Takahashi T; Nagai K; Yabe H; Kondo S; Hayashi Y
    Leuk Res; 2007 Jul; 31(7):921-9. PubMed ID: 17056111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias.
    Carluccio P; Mestice A; Pastore D; Delia M; Ricco A; Russo-Rossi A; Casieri P; Liso A; Martelli MP; Albano F; Specchia G
    Eur J Haematol; 2014 Feb; 92(2):121-6. PubMed ID: 24138595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
    Ferrara F; Criscuolo C; Riccardi C; Izzo T; Pedata M; Copia C; Vicari L; Tarsitano M; Palmieri S; Pane F
    Am J Hematol; 2009 Aug; 84(8):532-5. PubMed ID: 19562748
    [No Abstract]   [Full Text] [Related]  

  • 14. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
    Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
    Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
    Sritana N; Auewarakul CU
    Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
    Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
    Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
    Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
    J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
    Medeiros BC
    J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
    [No Abstract]   [Full Text] [Related]  

  • 19. Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3.
    Tsuji T; Takatsu N; Nosaka K; Kawakita T; Nanri T; Horikawa K; Mitsuya H; Asou N
    Leuk Res; 2010 Dec; 34(12):e320-2. PubMed ID: 20701971
    [No Abstract]   [Full Text] [Related]  

  • 20. Podocalyxin is expressed in normal and leukemic monocytes.
    Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
    Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.